ERBB2 and breast cancer: The risk of BC in women is strongly correlated with higher breast density and reduced breast fat for all tumor subtypes, with a stronger correlation among premenopausal women for hormone receptors-positive (ER+/PR+), human epidermal growth factor receptor 2-negative (HER2-) and triple-negative BC [6].